![James Knight](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James Knight
Corporate Officer/Principal chez SYNACT PHARMA AB
Fortune : 50 077 $ au 31/05/2024
Profil
James Knight's current job(s) include being the Chief Business Officer at SynAct Pharma AB, the Chief Business Officer at TXP Pharma GmbH, and the Head-Business Development at Biora Therapeutics, Inc. Mr. Knight's former job(s) include being the Director-Healthcare Consulting at Datamonitor, Inc., the Principal at Dura Pharmaceuticals, Inc., the Senior Vice President & Head-Corporate Development at Lineage Cell Therapeutics, Inc., and the Associate Scientist at Biogen, Inc. Additionally, he served as the Vice President-Portfolio Strategy at Questcor Pharmaceuticals, Inc. from 2010 to 2014, and as the Vice President-Global Strategic Marketing at Elan Pharmaceuticals LLC from 2001 to 2008.
Mr. Knight's education history includes obtaining an MBA from Northeastern University and an undergraduate degree from the University of Massachusetts.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
SYNACT PHARMA AB
0,19% | 20/06/2023 | 77 452 ( 0,19% ) | 50 077 $ | 31/05/2024 |
Postes actifs de James Knight
Sociétés | Poste | Début |
---|---|---|
SYNACT PHARMA AB | Corporate Officer/Principal | 11/02/2021 |
BIORA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
TXP Pharma GmbH | Corporate Officer/Principal | - |
Anciens postes connus de James Knight
Sociétés | Poste | Fin |
---|---|---|
QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2014 |
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Sales & Marketing | 01/01/2008 |
LINEAGE CELL THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Dura Pharmaceuticals, Inc.
![]() Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Corporate Officer/Principal | - |
Datamonitor, Inc.
![]() Datamonitor, Inc. Investment ManagersFinance Founded in 1995, Datamonitor, Inc. is an independent investment research firm located in New York City. The firm is the U.S. arm of UK-based Datamonitor Ltd. Datamonitor provides global business information, independent data and analysis and across the following sectors: (1) automotive (2) consumer packaged goods (3) energy and utilities (4) financial services (5) logistics and express (6) pharmaceuticals and healthcare and (7) retail | Corporate Officer/Principal | - |
Formation de James Knight
Northeastern University | Masters Business Admin |
University of Massachusetts | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
BIOGEN INC. | Health Technology |
SYNACT PHARMA AB | Health Technology |
BIORA THERAPEUTICS, INC. | Health Services |
Entreprise privées | 5 |
---|---|
Dura Pharmaceuticals, Inc.
![]() Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Dura Pharmaceuticals, Inc. markets and sells prescription products that treat infectious and respiratory diseases. Dura focuses on products and transactions that leverage its sales and marketing organization. Dura also intends, through the use of collaborative relationships, to develop the Spiros® motorized blisterdisk and Spiros® S2 pulmonary drug delivery systems for the local and systemic delivery of a wide range of medications. It is located in San Diego, CA. | Health Technology |
Questcor Pharmaceuticals, Inc.
![]() Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Health Technology |
Datamonitor, Inc.
![]() Datamonitor, Inc. Investment ManagersFinance Founded in 1995, Datamonitor, Inc. is an independent investment research firm located in New York City. The firm is the U.S. arm of UK-based Datamonitor Ltd. Datamonitor provides global business information, independent data and analysis and across the following sectors: (1) automotive (2) consumer packaged goods (3) energy and utilities (4) financial services (5) logistics and express (6) pharmaceuticals and healthcare and (7) retail | Finance |
TXP Pharma GmbH |